Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Mirali S, Fabusiwa K, Linos E. Safety in numbers: risankizumab for moderate-to-severe psoriasis. Br J Dermatol 2022 Feb 20. doi: 10.1111/bjd.20947.
PMID: 35187640


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016